Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Given Consensus Rating of “Buy” by Brokerages

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have been given a consensus recommendation of “Buy” by the six analysts that are currently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $12.13.

A number of analysts have weighed in on BIOX shares. Roth Mkm decreased their price target on Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday, September 11th. Canaccord Genuity Group decreased their target price on Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Oppenheimer cut their price target on Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a report on Monday, October 21st. Finally, Lake Street Capital lowered their price objective on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, September 11th.

Bioceres Crop Solutions Stock Performance

Shares of BIOX stock opened at $6.09 on Friday. The stock has a market capitalization of $382.74 million, a PE ratio of 304.65 and a beta of 0.51. The business’s 50 day simple moving average is $6.78 and its 200 day simple moving average is $8.91. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.27 and a quick ratio of 0.87. Bioceres Crop Solutions has a one year low of $5.71 and a one year high of $14.05.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its quarterly earnings data on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11). Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. The firm had revenue of $92.60 million during the quarter, compared to the consensus estimate of $117.15 million. During the same period in the prior year, the company posted ($0.07) earnings per share. As a group, research analysts forecast that Bioceres Crop Solutions will post 0.12 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Fourth Sail Capital LP increased its holdings in shares of Bioceres Crop Solutions by 61.6% during the third quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company’s stock valued at $24,957,000 after acquiring an additional 1,209,277 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. bought a new stake in Bioceres Crop Solutions during the 2nd quarter valued at $472,000. Ping Capital Management Inc. acquired a new position in Bioceres Crop Solutions during the second quarter worth $448,000. Dimensional Fund Advisors LP lifted its stake in shares of Bioceres Crop Solutions by 9.5% in the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after buying an additional 5,341 shares in the last quarter. Finally, Long Focus Capital Management LLC grew its holdings in shares of Bioceres Crop Solutions by 19.9% during the second quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company’s stock valued at $3,145,000 after buying an additional 46,647 shares during the last quarter. Institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.